Get started
Author

Ankur Tiwari

Towards a consensus definition of immune exclusion in cancer
2023 · Ankur Tiwari, Tamas Oravecz, et al. · Frontiers in Immunology · 104
PDF
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis
2023 · Elizabeth Lee Carpenter, Spencer Van Decar, et al. · Journal for ImmunoTherapy of Cancer · 24
PDF
Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis
2024 · Ankur Tiwari, Karl Alcover, et al. · Human Vaccines & Immunotherapeutics · 19
Tumor infiltrating lymphocytes as an endpoint in cancer vaccine trials
2023 · Patrick M. McCarthy, Franklin A. Valdera, et al. · Frontiers in Immunology · 18
PDF
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trial
2022 · Alexandra M. Adams, Elizabeth L. Carpenter, et al. · Cancer Immunology Immunotherapy · 14
PDF
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
2024 · Spencer G. Van Decar, Elizabeth L. Carpenter, et al. · Cancer Treatment and Research Communications · 5
Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters
2023 · Franklin A. Valdera, Anne E. O'Shea, et al. · Journal of Surgical Oncology · 4
The Binary Cellular Biology of Human Growth : I. Quantifying the Creation and Growth of the Body and its Parts
2025 · Philip Chodrow, Jessica Su, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
1143 Phase Iia Trial of Encapsulated Rapamycin (erapa) in Patients With Familial Adenomatous Polyposis to Reduce Intestinal Polyp Burden: 6 Month Interim Results
2024 · Carol A. Burke, Elena M. Stoffel, et al. · Gastroenterology · 1
Abstract 1046: Combination of CDK 4/6 inhibitor Palbociclib with Rapamycin synergistically inhibits the growth of hepatocellular carcinoma cells
2022 · Ankur Tiwari, Araceli Huerta, et al. · Cancer Research · 1
Abstract 4315: Co-activation of Wnt/β-catenin and c-MET induced inflamed hepatocellular carcinoma responsive to immune checkpoint therapy
2026 · Araceli Selena Bernal, Subash Khadka, et al. · Cancer Research
Abstract 1348: Investigation of sex disparity in hepatocarcinogenesis using a hydrodynamic tail vein injection mouse model
2025 · Araceli Selena Bernal, Morgana McLaughlin, et al. · Cancer Research
Abstract 772: Investigation of gender disparity in liver tumor formation using a hydrodynamic tail vein injection mouse model
2024 · Araceli Bernal, Morgana McLaughlin, et al. · Cancer Research
Abstract 2679: Combination of CDK 4/6 inhibitor palbociclib with rapamycin synergistically inhibits growth of hepatocellular carcinoma in preclinical models
2023 · Ankur Tiwari, Araceli Huerta, et al. · Cancer Research
Prolonged Survival Following Intra-abdominal Mycobacterium abscessus Infection Without Antimicrobial Therapy or Surgical Intervention
2022 · Ankur Tiwari, Matthew R. Geringer, et al. · The American Surgeon
Works count: 15
Citation count: 191
H-index: 5
I10-index: 5
Year
Topic
Type